Multivalent weak interactions enhance selectivity of interparticle binding
- PMID: 32859760
- PMCID: PMC7502730
- DOI: 10.1073/pnas.2003968117
Multivalent weak interactions enhance selectivity of interparticle binding
Abstract
Targeted drug delivery critically depends on the binding selectivity of cargo-transporting colloidal particles. Extensive theoretical work has shown that two factors are necessary to achieve high selectivity for a threshold receptor density: multivalency and weak interactions. Here, we study a model system of DNA-coated particles with multivalent and weak interactions that mimics ligand-receptor interactions between particles and cells. Using an optomagnetic cluster experiment, particle aggregation rates are measured as a function of ligand and receptor densities. The measured aggregation rates show that the binding becomes more selective for shorter DNA ligand-receptor pairs, proving that multivalent weak interactions lead to enhanced selectivity in interparticle binding. Simulations confirm the experimental findings and show the role of ligand-receptor dissociation in the selectivity of the weak multivalent binding.
Keywords: multivalency; particles; selectivity.
Copyright © 2020 the Author(s). Published by PNAS.
Conflict of interest statement
The authors declare no competing interest.
Figures




References
-
- Fasting C., et al. ., Multivalency as a chemical organization and action principle. Angw. Chem. Int. Ed. 51, 10472–10498 (2012). - PubMed
-
- Mammen M., Choi S., Whitesides G. M., Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angw. Chem. Int. Ed.Engl. 37, 2754–2794 (1998). - PubMed
-
- Karimi F., O’Connor A. J., Qiao G. G., Heath D. E., Integrin clustering matters: A review of biomaterials functionalized with multivalent integrin-binding ligands to improve cell adhesion, migration, differentiation, angiogenesis, and biomedical device integration. Adv. Healtc. Mater. 7, e1701324 (2018). - PubMed
-
- Bhatia S., Camacho L. C., Haag R., Pathogen inhibition by multivalent ligand architectures. J. Am. Chem. Soc. 138, 8654–8666 (2016). - PubMed